PACTR202206525204526招募中4 期
AIRE RESEARCH PROTOCOL: «EVALUATING THE OPERATIONAL IMPLEMENTATION OF DECENTRALIZED PULSE OXYMETER IN CHILDREN»
ALIMA NGO0 个研究点目标入组 40,000 人开始时间: 2022年6月7日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Day(s) 至 1 Month(s)（—）
- 性别
- All
入选标准
- •The PO will be used among the following eligible children according to the IMCI classification and depending on age and signs:
- •0-59 days: All sick children.
- •2-59 months, with cough and breathing difficulties: All sick children (green, yellow or red)
- •2-59 months, without cough and breathing difficulties: those classified as moderate (yellow) or severe (red).
- •All neonates (0 to 59 days) and children (2 to 59 months) attending IMCI consultation in research sites of the AIRE project will be screened for PO use eligibility criteria detailed above by the health care professional working at the PHCs.
- •Those eligible for whom at least one caregiver has given consent will be enrolled over the recruitment period
排除标准
- 未提供
研究者
相似试验
已完成
不适用
PILOT STUDY PROTOCOL: LOW-PRESSURE PNEUMOPERITONEUM WITH DEEP NEUROMUSCULAR BLOCKADE IN BARIATRIC SURGERY TO REDUCE POSTOPERATIVE PAINL-OMON44329Sint Franciscus Gasthuis60
招募中
2 期
Open uncontrolled investigation to evaluate the efficacy and safety of the granulocytes/ monocytes apheresis with the Adacolumn for the treatment of severe alcoholic hepatitissevere alcoholic hepatitisJPRN-UMIN000008642Division of Gastroenterology & Hepatology, Department of Internal Medicine, School of Medicine, Keio University20
已完成
不适用
Air for Infant Resuscitatiopremature birthrespiratory distressnewborn resuscitationReproductive Health and Childbirth - Complications of newbornRespiratory - Normal development and function of the respiratory systemReproductive Health and Childbirth - Childbirth and postnatal careACTRN12620001252909Royal Hospital for Women79
暂停
1 期
MINIMALLY INVASIVE PROCEDURE FOR GLAUCOMA TREATMENTCTRI/2019/08/020913Appasamy Ocular Devices Pvt Ltd
进行中（未招募）
不适用
A phase II, open label study to evaluate the activity and safety of Everolimus in association to Imatinib in PDGFRA-D842V unresectable or metastatic gastrointestinal stromal tumours (GISTs)as first line treatment - NDEUCTR2010-020305-32-ITISTITUTO NAZIONALE PER LA CURA TUMORI